Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
MADISON, Wis., July 1 /PRNewswire/ -- Cellular Dynamics International (CDI) and Roche announced today a significant expansion of their existing agreement to test drug development candidates for their potential to cause cardiotoxicity, or damage to heart tissue. The two-year collaboration a...
ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on Its Octet(R) Platform
MENLO PARK, Calif., May 27 /PRNewswire/ -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced that it has launched two new assay modules - for high-sensitivity protein quantitation and fragm...
Sigma-Aldrich Introduces Precisio(TM) Kinases for High-Throughput Screening and Kinase Profiling
ST. LOUIS, May 13 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) today introduced Precisio(TM) Kinases ( www.sigma.com/precisiokinases ), a new collection of high quality active kinases that is expected to enable scientists to achieve greater insight into protein phosphorylation and c...
QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
VENLO, Netherlands and KOLKATA, India, April 21 /PRNewswire-Asia/ --
QIAGEN and the Chittaranjan National Cancer Institute (CNCI) today announced a
collaboration to establish the first large-scale cervical cancer screening
program for women in Kolkata, India. QIAGEN (Nasdaq: QGEN ; Frankfur...
New Discoveries on a Fingertip Test for Screening Silent Heart Disease Promising Results of Recent Clinical Studies to be Presented during the 2009 American College of Cardiology Conference, March 29th - April 1st in Orlando
Results of five clinical studies evaluating the predictive value of VENDYS®, the new FDA-approved cardiovascular test, will be presented at the 2009 Annual Scientific Sessions of the American College of Cardiology in Orlando, Florida. The studies, amazingly, show that a simple, inexpensive te...
EPA Presents Initial Results from Caliper Life Sciences' ToxCast Screening Effort
- EPA Exercises Option to Extend Contract with Caliper -
HOPKINTON, Mass., March 19 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today announced that the United States Environme...
Sigma-Aldrich Introduces MISSION(R) LentiPlex(TM) Pooled shRNA Libraries to Enable Rapid Whole Genome Screening in Primary Cells, Stem Cells or Tumor Cells
ST. LOUIS, March 3 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) today announced the global release of the MISSION(R) LentiPlex(TM) Pooled Human and Murine shRNA Libraries ( http://www.sigma-aldrich.com/lentiplex ). Using the shRNA collections of The RNAi Consortium (TRC), the ...
ScreenCancer Adds InSure(R) FIT(TM) Colorectal Cancer Screening Test to European Cancer Screening Program
OSLO, Norway, February 26 /PRNewswire/ -- ScreenCancer AS, a Norwegian
company offering cancer screening
management services to employers, insurance
companies and individuals, today announced that it has added the InSure(R)
FIT(TM) take-at-home colorectal cancer screening
test to its European ...
New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
Study Published in British Medical Journal Indicates Masimo SET May Also Reduce the Need for Pre-Operative Neonatal Intensive Care and Prevent Long-term Neurological Morbidity
IRVINE, Calif., Jan. 30 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry and...
Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum
PHILADELPHIA, Pennsylvania and REHOVOT Israel, January 16
/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq: ROSG ) and
collaborators, today unveiled initial data relating to the company's
colorectal cancer screening
diagnostics test, miRscreen(TM) colon, which is
based on a simple bloo...
Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market.
GOTHENBURG, Sweden, December 3 /PRNewswire/ -- Cellectricon, a leading
provider of screening
solutions for drug discovery, today announced the
signing of a collaborative agreement with The Automation Partnership (TAP) in
the UK, manufacturers of advanced automated systems for cell culture, sample
Celsis Launches RapiScreen(TM) Beverage Microbial Screening System
CHICAGO, Nov. 20 /PRNewswire/ -- Celsis International plc
(LSE: CEL.L), the global leader in rapid microbial detection solutions for
industry, today announced the launch of RapiScreen(TM) Beverage, a new assay
for use on the Celsis Innovate -- the company's proven rapid microbial
Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer
MEXICO CITY, Mexico, November 19 /PRNewswire-FirstCall/ -- In a campaign
to significantly reduce the most common cancer affecting Mexican women, the
Mexican Public Health Agency (Secretaria de Salud or SSA) has announced it is
launching the first phase of a program that will offer testing for huma...
Cellectricon Receives Milestone Order for Cellaxess(R)HT, the World's First High Throughput RNAi Screening System
GOTHENBURG, Sweden, November 12 /PRNewswire/ -- Cellectricon, a leading
provider of advanced screening
solutions for drug discovery, has today
received its most significant and largest single order to date. The order
includes three Cellaxess(R)HT systems and the customer is a leading US
MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
GAITHERSBURG, Md., Nov. 12 /PRNewswire-USNewswire/ -- MaxCyte, Inc.,
the pioneer in scalable, high performance cell loading systems, announces
that it will be hosting a live discussion with industry experts on the
challenges in developing cell-based screening
assays for drug discovery.
The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use
Majority of Physicians are Most Concerned About Lack of Reimbursement for
Vascular Catheter-Associated Infections, According to a New Report from Decision Resources
WALTHAM, Mass., Nov. 3 /PRNewswire/ -- Decision Resources, one of the
world's leading research and adv...
Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
LONDON, Oct. 7 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a
biopharmaceutical company focused on the development of novel
anti-inflammatory drugs, announced today the results of the ongoing
screening of its novel anti-inflammatory drugs using MD Biosciences'
Immunoprofiler(TM) in vitro scr...
Caliper Life Sciences Receives $1.1 Million Task Order from the EPA's ToxCast(TM) Screening Program
- Caliper Screens Compounds to Detect Toxicity -
HOPKINTON, Mass., Aug. 19 /PRNewswire-FirstCall/ -- Caliper Life
Sciences, Inc. (Nasdaq: CALP ) today announced that it has received a $1.1
million task order under the United States Environmental Protection
Agency's (EPA) ToxCast(T...
FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
- Test Cleared to Screen Donated Blood for Hepatitis B, as well as HIV-1 and Hepatitis C, on Fully and Semi-Automated Instrument Systems -
SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated
(Nasdaq: GPRO ) announced today that the US Food and Drug Administration
(FDA) has a...
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
BASEL, Switzerland and TORONTO, July 23 /PRNewswire-FirstCall/ - Roche
(SWX: ROG) and ARIUS Research Inc. (TSX:ARI) today announced that the two
companies have signed a definitive agreement for Roche to acquire ARIUS in
an all-cash transaction at a price of approximately C$191 million. ARIUS i...
TIBCO Spotfire Puts the Spotlight on Screening at InfoTech for Pharma and Biotech
Christian Marcazzo's Presentation at May Conference to Show How Pharma Research Benefits from Advances in Analytics
SOMERVILLE, Mass., May 20 /PRNewswire-FirstCall/ -- Spotfire, a
division of TIBCO Software Inc. (Nasdaq: TIBX ), today announced that
Christian Marcazzo, Senior Di...
Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
CAMBRIDGE, Mass., May 8 /PRNewswire/ -- In response to ever increasing
cardiac toxicity found in market drugs, Gwathmey Preclinical Testing
Services, Inc. today announced the launch of new Cardionomics(TM) services
and the formation of its Cardionomics(TM) Advisory Board to provide new
Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research
CENTER VALLEY, Pa., April 4, 2008 /PRNewswire/ -- Scientists in fields
as diverse as pharmaceutical research, food science and biology will
benefit from the Olympus FluoroPoint(TM) single molecule fluorescence
detection system for molecular interaction analysis. Already in use in
scores of lab...
Liberty Screening Services Hires Top Executive to Meet Explosive Demand for its Background-Screening Services
HOUSTON, March 31 /PRNewswire/ -- Sherry Jones, PHR, is the new
national sales director for rapidly expanding Liberty Screening
The company creates uniform background-screening strategies for many
Fortune 500/1000 clients and smaller companies through proprietary,
real-time online so...
Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
'Do You Have the Guts?' aims to reach five million in five years
MADISON, N.J., March 31 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX ), the nation's leading provider of diagnostic
testing information and services, today announced the launch of a novel
Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery
HAMBURG, Germany and OXFORD, England and OSLO, March 12
/PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT)
announced today that Spermatech A/S has chosen them as a partner to
identify small molecule therapeutics for their pharmaceutical discovery
Through the study o...
Colon Cancer Screening Laws Now Cover Half of U.S. Population
Five States Passed Laws in 2007, but 26 Still Earn D's or F's on Legislation Report Card
WASHINGTON, March 11 /PRNewswire-USNewswire/ -- For the first time,
more than half of the U.S. population is now covered by state laws that
require insurance providers to cover t...
National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM)
2008 NFPA 1584 establishes the routine use of Pulse CO-Oximetry as a way to
protect the lives of the nation's firefighters from the dangers of CO Poisoning
IRVINE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Masimo (Nasdaq:
MASI), the inventor of Pulse CO-Oximetry ...
National Association of Emergency Medical Technicians (NAEMT) Supports Prehospital Screening for Carbon Monoxide in the Blood
Association heightens awareness for significant public health hazard of CO
poisoning and advises screening
of CO levels in the blood as a way to meet the challenge and improve the quality of care
IRVINE, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Masimo (Nasdaq:
MASI), the inventor ...
Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
ABBOTT PARK, Ill., Jan. 18 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT )
announced today it received approval from the U.S. Food and Drug
Administration for its fully automated HTLV-I/HTLV-II blood screening
for use on the ABBOTT PRISM instrument. The test is intended for use by
International Association of Fire Fighters (IAFF) Advocates Screening Fire Fighters for Carbon Monoxide Poisoning Using Pulse CO-Oximetry
Union believes many cardiac arrests experienced by fire fighters may be attributable to CO exposure
IRVINE, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI ),
the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion
pulse oximetry, today a...
Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy
MELBOURNE, Australia, Nov. 14 /PRNewswire/ -- Swiss experts have
abandoned the over 100 year old tuberculin skin test (TST) favouring the
use of interferon-a release assays such as QuantiFERON(R)-TB Gold (QFT(TM))
patients for tuberculosis (TB) infection prior to initiating
Enigma Diagnostics to Develop Clinical Diagnostics Platform for UK National Chlamydia Screening Programme
New DNA-Based Test Produces Decisive Result Within Minutes
PORTON DOWN, England, November 9 /PRNewswire/ -- Enigma Diagnostics,
the life sciences company developing rapid molecular diagnostics and
detection systems, announces that it has successfully completed a project
commissioned by ...
BioReliance Launches Next-Generation Genotoxicity Screening Service
ROCKVILLE, Md., Sept. 12 /PRNewswire/ -- BioReliance Corporation, a
leading contract services organization for the biopharmaceutical and
pharmaceutical industries, has contracted with Gentronix to offer their
GreenScreen HC in vitro assay as a major part of BioReliance's portfolio of
NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
Pharmaceutical Industry Veteran Richard Franco and Entrepreneur Anthony Ciabattoni Join NeoMatrix Board of Directors
IRVINE, Calif., Sept. 5 /PRNewswire/ -- NeoMatrix, developer of the
HALO(TM) Breast Pap Test, the first automatic, noninvasive test designed to
identify breast canc...
Sigma-Aldrich Introduces MISSION(R) esiRNA for Low Cost, High Specificity Pooled RNAi Screening
ST. LOUIS, April 28 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) today announced the global release of MISSION(R) esiRNA, a pool of gene-specific siRNA that provides a novel and powerful approach to RNAi screening
in mammalian cells. Unlike traditional synthetic RNAi, esiRNA ( htt...
Jubilant Biosys Launches Legend NGSS(TM) Advanced Software Solution for High-Throughput Drug Molecule Screening
NOIDA, India, Jan. 21 /PRNewswire/ -- Jubilant Organosys Ltd,
headquartered in Noida near New Delhi, announced today that its subsidiary
Jubilant Biosys Ltd., based in Bangalore, has developed a next generation
screening solution, Legend NGSS(TM), that will further enable the process of
Dorset County Hospital Enhances MRSA Surveillance Programme Through Rapid Patient Screening
Dorset County Hospital screens elective and Orthopaedic admissions patients
in only 75 minutes using Cepheid's advanced Xpert(TM) MRSA technology
DORSET, England, Nov. 4 /PRNewswire/ -- Dorset County Hospital (DCH) is
working hard to reduce MRSA infections and, as part of that plan, has
GeneNews launches world's first blood test for colorectal cancer screening
TORONTO, July 21 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN),
a company focused on developing blood-based biomarker tests for the early
detection of diseases and personalized health management, today announced
the launch of ColonSentry(TM), the world's first blood-based molecular test...
AFL To Return to Oklahoma Due to Overwhelming Demand for Signalife Heart Screening
LOS ANGELES, July 16 /PRNewswire-FirstCall/ -- Due to overwhelming
demand for ambulatory heart tests performed by the Athletes for Life
Foundation, Inc. ("AFL" or the "Foundation") using Signalife, Inc.'s (Amex:
SGN) award winning Fidelity 100 ECG system, AFL is returning to Ada,
Oklahoma, to ...